BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8569175)

  • 1. Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.
    Lakhani SR; Slack DN; Hamoudi RA; Collins N; Stratton MR; Sloane JP
    Lab Invest; 1996 Jan; 74(1):129-35. PubMed ID: 8569175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
    Selim AG; Ryan A; El-Ayat G; Wells CA
    J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
    Selim AG; Ryan A; El-Ayat GA; Wells CA
    Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
    J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
    Ellsworth DL; Ellsworth RE; Love B; Deyarmin B; Lubert SM; Mittal V; Shriver CD
    Breast Cancer Res Treat; 2004 Nov; 88(2):131-9. PubMed ID: 15564796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva.
    Pinto AP; Lin MC; Sheets EE; Muto MG; Sun D; Crum CP
    Gynecol Oncol; 2000 Apr; 77(1):171-6. PubMed ID: 10739707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.
    Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ
    Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast.
    Jones C; Merrett S; Thomas VA; Barker TH; Lakhani SR
    J Pathol; 2003 Feb; 199(2):152-6. PubMed ID: 12533827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast.
    Diallo R; Schaefer KL; Poremba C; Shivazi N; Willmann V; Buerger H; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 2001 Jan; 193(1):27-32. PubMed ID: 11169512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.
    Lakhani SR; Collins N; Stratton MR; Sloane JP
    J Clin Pathol; 1995 Jul; 48(7):611-5. PubMed ID: 7560165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
    Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic divergence in the clonal evolution of breast cancer.
    Fujii H; Marsh C; Cairns P; Sidransky D; Gabrielson E
    Cancer Res; 1996 Apr; 56(7):1493-7. PubMed ID: 8603391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of apocrine proliferations of the breast: a morphologic approach.
    Masood S; Rosa M
    Pathol Res Pract; 2009; 205(3):155-64. PubMed ID: 19147303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of critical genetic changes in human breast disease.
    Ellsworth RE; Ellsworth DL; Deyarmin B; Hoffman LR; Love B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2005 Dec; 12(12):1054-60. PubMed ID: 16228814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
    Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
    Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.